Here's what 3 brokers think of the Macquarie (ASX:MQG) share price

Brokers have given their verdict on the Macquarie share price…

The Macquarie Group Ltd (ASX: MQG) share price is trading lower again on Tuesday.

The investment bank's shares are currently down 1% to $171.74.

This means the Macquarie share price is now down 6% from the record high of $182.66 it reached last week.

Female ASX investor standing with back to camera, reviewing screen of share price charts in front of her

Image source: Getty Images

Is the Macquarie share price in the buy zone?

A number of brokers have been giving their verdict on the Macquarie share price and have very different opinions.

For example, the team at Ord Minnett are positive on the company. They have an accumulate rating and $190.00 price target on its shares.

Based on the current Macquarie share price, this implies potential upside of ~11% before dividends.

Ord Minnett is confident on the investment bank's long term growth prospects and believes its shares are reasonably priced.

Neutral view

Over at Goldman Sachs, its analysts are sitting on the fence. Goldman has a neutral rating and $170.62 price target on the company's shares. This is broadly in line with where its shares are trading today.

The broker commented: "The earnings upgrade cycle continues for MQG and since troughing in May-20, its 12-mo forward EPS has risen 52%, and sits within 2% of its Apr-19 peak. However, since Apr-19, its share price is nearly one-third higher. Therefore, with MQG currently trading on a 12-mo forward P/E of 20.5x, with incremental earnings upgrades still coming largely from investment income and trading, we stay Neutral."

The bear

Finally, the team at Citi believe the Macquarie share price is overvalued at the current level.

Earlier this month, the broker put a sell rating and $153.00 price target on the company's shares. This implies potential downside of 11% over the next 12 months.

While Citi acknowledges that its guidance upgrade was a positive surprise, it isn't enough for a change of rating.

Citi explained: "MQG has provided guidance for the 1H22 result to be 'slightly down' on 2H21, implying a range of ~$1.8-2.0bn of NPAT for the half. As we flagged recently, this implies another quarter where profitability has approached $1bn. This sees 1H22 earnings as being materially ahead of consensus (Visible Alpha $1.55bn), but slightly ahead of CitiE (prior forecast $1.78bn)."

"The stock has reacted positively to the guidance upgrade (+5%), but consensus is largely upgrading on the back of one-time MIC wind-down revenues. At 22x FY23 earnings the stock remains expensive in our view," it concluded.

Time will tell which broker makes the right call.

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia owns shares of and has recommended Macquarie Group Limited. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on Broker Notes

Happy wife holding her hands on her husband's shoulders while both look at a laptop.
Broker Notes

Top brokers name 3 ASX shares to buy next week

Brokers gave buy ratings to these ASX shares last week. Why are they bullish?

Read more »

a man wearing a hard hat and a high visibility vest stands with his arms crossed in front of heavy equipment at a mine site.
Broker Notes

BHP share price drops 13% to seven-month low in just 1 week. Do experts say buy?

Market analysts offer their advice as BHP shares plunge this week.

Read more »

A distressed young woman reads bad news on her smartphone while standing in a modern indoor setting.
Broker Notes

5 ASX 200 shares experts recommend we buy amid the market carnage this week

ASX 200 shares are down 5.2% this week and back in the red for 2026 overall.

Read more »

Comical investor reading documents and surrounded by calculators.
Broker Notes

Buy, hold, sell: Hub24, Reece, Ramsay Healthcare shares

Analysts reveal their ratings on this financial services provider, plumbing supplies company, and private hospital operator.

Read more »

A man with his back to the camera holds his hands to his head as he looks to a jagged red line trending sharply downward.
Broker Notes

Three of the worst performers in the ASX 200. Brokers think they're ready to bounce back

There could be a lot of value in these poor performers.

Read more »

Business man marking buy on board and underlining it.
Broker Notes

Leading brokers name 3 ASX shares to buy today

Brokers believe that now could be the time to buy these shares.

Read more »

Medical workers examine an x-ray or scan in a hospital laboratory.
Broker Notes

2 ASX shares tipped to grow up to 122% in the next 12 months

These companies could be on the cusp of something big.

Read more »

Thumbs down Facebook icon over dark screen.
Broker Notes

Why these 5 ASX shares were downgraded by brokers this week

Market analysts explain why they've downgraded these ASX stocks.

Read more »